Use of snus and acute myocardial infarction: Pooled analysis of eight prospective observational studies

European Journal of Epidemiology

Volumn 27, Issue 10, 2012, Pages 771-779

  Hansson, Jenny ^a   Galanti, Maria Rosaria ^a   Hergens, Maria Pia ^a   Fredlund, Peeter ^a   Ahlbom, Anders ^a   Alfredsson, Lars ^a   Bellocco, Rino ^a,b   Eriksson, Marie ^c   Hallqvist, Johan ^d   Hedblad, Bo ^e   Jansson, Jan Håkan ^c   Nilsson, Peter ^e   Pedersen, Nancy ^a   Lagerros, Ylva Trolle ^a   Östergren, Per Olof ^f   Magnusson, Cecilia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UMEÅ UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Acute myocardial infarction; Smokeless tobacco; Snus; The swedish collaboration on health effects of snus use

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; FOLLOW UP; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; RISK FACTOR; SMOKELESS TOBACCO; SOCIOECONOMICS; SURVIVAL; SWEDISH MOIST SMOKELESS TOBACCO;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TOBACCO, SMOKELESS;

EID: 84871293459     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9704-8     Document Type: Article

References (46)

1. Lambe M. Swedish snus for tobacco harm reduction. Lancet. 2007;370(9594):1206-7. (1206; author reply).
2. Foulds J, Kozlowski L. Snus-what should the public-health response be? Lancet. 2007;369(9578):1976-8.
3. European Commission. Health effects of smokeless tobacco products: Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Brussels. 2007.
4. Holm LE, Fisker J, Larsen BI, Puska P, Halldorsson M. Snus does not save lives: Quitting smoking does! Tob control. 2009; 18(4):250-1.
5. Stenbeck M, Hagquist C, Rosen M. The association of snus and smoking behaviour: A cohort analysis of Swedish males in the 1990s. Addiction (Abingdon, England). 2009;104(9):1579-85.
6. Gilljam H, Galanti MR. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction (Abingdon, England). 2003;98(9):1183-9.
7. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9(7):667-75.
8. Nordenvall C, Nilsson PJ, Ye W, Nyren O. Smoking, snus use and risk of right-and left-sided colon, rectal and anal cancer: A 37-year follow-up study. Int J Cancer. 2011;128(1):157-65.
9. England LJ, Levine RJ, Mills JL, Klebanoff MA, Yu KF, Cnattingius S. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003;189(4):939-43.
10. Wikstrom AK, Cnattingius S, Galanti MR, Kieler H, Stephansson O. Effect of Swedish snuff (snus) on preterm birth. BJOG. 2010;117(8):1005-10.
11. Wikstrom AK, Cnattingius S, Stephansson O. Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiology (Cambridge, Mass). 2010;21(6):772-8.
12. Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology. 1992;108(4):507-11.
13. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med. 1997;26(4):412-7.
14. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: Is snuff less dangerous than cigarettes? BMJ (Clinical research ed.). 1992;305(6864):1252-6.
15. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: A population-based study in middle-aged men. J Am Coll Cardiol. 1999;34(6):1784-90.
16. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology (Cambridge, Mass). 2005;16(1):12-6.
17. Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: A 12-year follow-up study. Eur J Cardiovasc Prev Rehabil. 2005;12(4):387-92.
18. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med. 2007;262(3): 351-9.
19. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med. 2007;262(3):360-7.
20. Haglund B, Eliasson M, Stenbeck M, Rosen M. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J public Health. 2007;35(6):618-22.
21. Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, Hallqvist J, Magnusson C. Use of snus and risk for cardiovascular disease: Results from the Swedish Twin Registry. J Intern Med. 2009;265(6):717-24.
22. Janzon E, Hedblad B. Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord. 2009;9:21.
23. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994; 84(3):399-404.
24. Carlsson F, Merlo J, Lindstrom M, Ostergren PO, Lithman T. Representativity of a postal public health questionnaire survey in Sweden, with special reference to ethnic differences in participation. Scand J public health. 2006;34(2):132-9.
25. Eriksson M, Holmgren L, Janlert U, Jansson JH, Lundblad D, Stegmayr B, Soderberg S, Eliasson M. Large improvements in major cardiovascular risk factors in the population of northern Sweden: The MONICA study 1986-2009. J Intern Med. 2011; 269(2):219-31.
26. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G. The Malmo diet and cancer study: Representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001;10(6): 489-99.
27. Alfredsson L, Hammar N, Fransson E, de Faire U, Hallqvist J, Knutsson A, Nilsson T, Theorell T, Westerholm P. Job strain and major risk factors for coronary heart disease among employed males and females in a Swedish study on work, lipids and fibrinogen. Scand J Work Environ Health. 2002;28(4):238-48.
28. Bellocco R, Jia C, Ye W, Lagerros YT. Effects of physical activity, body mass index, waist-to-hip ratio and waist circumference on total mortality risk in the Swedish National March Cohort. Eur J Epidemiol. 2010;25(11):777-88.
29. Lichtenstein P, Sullivan PF, Cnattingius S, Gatz M, Johansson S, Carlstrom E, Bjork C, Svartengren M, Wolk A, Klareskog L, et al. The Swedish Twin Registry in the third millennium: An update. Twin Res Hum Genet. 2006;9(6):875-82.
30. Hansson J, Galanti MR, Magnusson C, Hergens MP. Weight gain and incident obesity among male snus users. BMC Public Health. 2011;11:371.
31. Norberg M, Wall S, Boman K, Weinehall L. The vasterbotten intervention programme: Background, design and implications. Glob Health Action. 2010; 3:4643. doi:10.3402/gha.v3i0.4643.
32. Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis. 1995;113(1):41-53.
33. Lundqvist G, Sandstrom H, Ohman A, Weinehall L. Patterns of tobacco use: A 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scand J Public Health. 2009;37(2):161-7.
34. Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K. Evolving patterns of tobacco use in northern Sweden. J Intern Med. 2003;253(6):660-5.
35. Furberg H, Lichtenstein P, Pedersen NL, Bulik C, Sullivan PF. Cigarettes and oral snuff use in Sweden: Prevalence and transitions. Addiction (Abingdon, England). 2006;101(10):1509-15.
36. Hammar N, Alfredsson L, Rosen M, Spetz CL, Kahan T, Ysberg AS. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol. 2001;30(Suppl 1):S30-4.
37. Lee PN. Circulatory disease and smokeless tobacco in Western populations: A review of the evidence. Int J Epidemiol. 2007; 36(4):789-804.
38. Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: Systematic review with metaanalysis. BMJ (Clinical research ed.). 2009;339:b3060.
39. Galobardes B, Lynch J, Smith GD. Measuring socioeconomic position in health research. Br Med Bull. 2007;81-82:21-37.
40. Peltonen M, Rosen M, Lundberg V, Asplund K. Social patterning of myocardial infarction and stroke in Sweden: Incidence and survival. Am J Epidemiol. 2000;151(3):283-92.
41. Engstrom K, Magnusson C, Galanti MR. Socio-demographic, lifestyle and health characteristics among snus users and dual tobacco users in Stockholm County Sweden. BMC Public Health. 2010;10:619.
42. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: A meta-analysis. Addiction (Abingdon, England). 2000;95(10):1505-23.
43. Yashima M, Ohara T, Cao JM, Kim YH, Fishbein MC, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine increases ventricular vulnerability to fibrillation in hearts with healed myocardial infarction. Am J Physiol Heart Circ Physiol. 2000;278(6):H2124-33.
44. Ohara T, Yashima M, Hamzei A, Favelyukis M, Park A, Kim YH, Mandel WJ, Chen PS, Karagueuzian HS. Nicotine Increases Spatiotemporal Complexity of Ventricular Fibrillation Wavefront on the Epicardial Border Zone of Healed Canine Infarcts. J Cardiovasc Pharmacol Ther. 1999;4(2):121-7.
45. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac Arrhythmias Following Intravenous Nicotine: Experimental Study in Dogs. J Cardiovasc Pharmacol Ther. 1997;2(4):291-8.
46. Martin JS, Beck DT, Gurovich AN, Braith RW. The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics. Exp Biol Med (Maywood). 2010; 235(10):1263-8.